Document Detail


Assay development and screening of human DGAT1 inhibitors with an LC/MS-based assay: application of mass spectrometry for large-scale primary screening.
MedLine Citation:
PMID:  20484097     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Many attractive targets for therapeutic intervention are enzymes that catalyze biological reactions involving small molecules such as lipids, fatty acids, amino acid derivatives, nucleic acid derivatives, and cofactors. Some of the reactions are difficult to detect by methods commonly used in high-throughput screening (HTS) without specific radioactive or fluorescent labeling of substrates. In addition, there are instances when labeling has a detrimental effect on the biological response. Generally, applicable assay methodologies for detection of such reactions are thus required. Mass spectrometry (MS), being a label-free detection tool, has been actively pursued for assay detection in HTS in the past several years. The authors have explored the use of multiparallel liquid chromatography coupled with tandem mass spectrometry (LC/MS/MS) for high-throughput detection of biochemical reactions. In this report, we describe in detail the assay development and screening with a LC/MS-based system for inhibitors of human diacylglycerol acyltransferase (DGAT1) with a chemical library of approximately 800,000 compounds. Several strategies and process improvements have been investigated to overcome technical challenges such as data variation and throughput. Results indicated that, through these innovative approaches, the LC/MS-based screening method is both feasible and suitable for high-throughput primary screening.
Authors:
Ji-Hu Zhang; Thomas P Roddy; Pei-I Ho; Christopher R Horvath; Chad Vickers; Steven Stout; Brian Hubbard; Y Karen Wang; W Adam Hill; Dejan Bojanic
Related Documents :
14632387 - Liquid chromatographic determination of pyrantel tartrate in medicated formulations.
15941677 - Automated on-line spe lc-ms/ms method to quantitate 6beta-hydroxycortisol and cortisol ...
9656157 - Comparison of lc detection methods in the investigation of non-uv detectable organic im...
19797517 - Classification of amyloidosis by laser microdissection and mass spectrometry-based prot...
22468347 - Detection of salmonella in meat: comparative and interlaboratory validation of a noncom...
6425347 - Rapid determination of aflatoxin b1 in dutch feeding stuffs by high-performance liquid ...
Publication Detail:
Type:  Journal Article     Date:  2010-05-18
Journal Detail:
Title:  Journal of biomolecular screening     Volume:  15     ISSN:  1552-454X     ISO Abbreviation:  J Biomol Screen     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-07-16     Completed Date:  2010-11-04     Revised Date:  2011-05-23    
Medline Journal Info:
Nlm Unique ID:  9612112     Medline TA:  J Biomol Screen     Country:  United States    
Other Details:
Languages:  eng     Pagination:  695-702     Citation Subset:  IM    
Affiliation:
Center for Proteomic Chemistry, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA. ji-hu.zhang@novartis.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chromatography, Liquid
Diacylglycerol O-Acyltransferase / antagonists & inhibitors*,  metabolism
Drug Evaluation, Preclinical / methods*
Enzyme Assays / methods*
Enzyme Inhibitors / analysis*,  pharmacology*
High-Throughput Screening Assays
Humans
Mass Spectrometry / methods*
Reference Standards
Reproducibility of Results
Solvents / chemistry
Time Factors
Titrimetry
Chemical
Reg. No./Substance:
0/Enzyme Inhibitors; 0/Solvents; EC 2.3.1.20/Diacylglycerol O-Acyltransferase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cross-cultural Adaptation, Reliability and Validity of the DAFS-R in a Sample of Brazilian Older Adu...
Next Document:  Immediate Percutaneous Coronary Intervention Is Associated With Better Survival After Out-of-Hospita...